Clinical Trial

Right Ventriculo-Arterial Coupling During Fluid Loading in ICU Patients

Study acronym: RVPA-FLICU
Recruiting
View on ClinicalTrials.gov →
Summary
Preload responsiveness and venous congestion have largely been investigated independently in recent literature. However, recent data report a similar incidence of venous congestion regardless of fluid responsiveness status, challenging the concept of a linear continuum between preload independence and fluid intolerance. These findings support the need for a more individualized hemodynamic management strategy that takes venous congestion risk into account. The right ventricle plays a central role in this framework. Its function is to maintain an adequate venous return pressure gradient to ensure cardiac output while limiting upstream venous congestion, under strong dependence on its afterload. In physiological conditions, the right ventricle adapts to changes in afterload by increasing contractility to preserve right ventriculo-arterial coupling and optimize its performance. In chronic cardiopulmonary diseases, right ventriculo-arterial uncoupling is a well-established prognostic factor, including the presence of occult uncoupling revealed by fluid loading. In critically ill patients, right ventricular systolic dysfunction associated with venous congestion-defining right heart failure-is strongly associated with increased mortality, as is right ventriculo-arterial uncoupling itself. To support the concept of fluid tolerance, the investigators hypothesize that impairment of right ventriculo-arterial coupling may exist or occur during fluid loading in critically ill patients, independently of preload responsiveness, and may be associated with worsening upstream venous congestion.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-11
notable Primary completion pushed: 2029-05 -> 2029-06-04 2026-06-11
minor Completion pushed: 2029-05 -> 2029-06-04 2026-06-11
Trial Details
NCT Number NCT07537621
Lead Sponsor CHU de Reims
Conditions Shock, Right Ventricular Dysfunction, Venous Congestion
Enrollment 100 participants
Start Date 2026-06-03
Primary Completion 2029-06-04 (estimated)
Study Completion 2029-06-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-10